BackSierra Oncology Overview

Sierra Oncology EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SRRA.

Quarterly EBIT

-$27.94M
↓ 40.79% YoY

As of Mar 31, 2022

Annual EBIT (TTM)

-$102.76M
↓ 49.41% YoY

Trailing 12 months ending Mar 31, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin